Summary: Overactive p53 has been proposed as an important pathophysiological factor for bone marrow failure syndromes, including Fanconi anemia (FA). Here, we report a p53-dependent effect on hematopoietic stem and progenitor cell (HSPC) proliferation in mice deficient for the FA gene Fanca. Deletion of p53 in Fanca−/− mice leads to replicative exhaustion of the hematopoietic stem cell (HSC) in transplant recipients. Using Fanca−/− HSCs expressing the separation-of-function mutant p53515C transgene, which selectively impairs the p53 function in apoptosis but keeps its cell-cycle checkpoint activities intact, we show that the p53 cell-cycle function is specifically required for the regulation of Fanca−/− HSC proliferation. Our results demons...
Bone marrow failure (BMF) in Fanconi anemia (FA) patients results from dysfunctional hematopoietic s...
Hypersensitivity to cross-linking agents such as mitomycin C (MMC) is characteristic of cells from p...
Hematopoietic stem cells (HSCs) preserve their ability to self-renew and differentiate to different ...
Overactive p53 has been proposed as an important pathophysiological factor for bone marrow failure s...
AbstractFanconi anemia patients suffer from progressive bone marrow failure. An overactive p53 respo...
SummaryOur mechanistic understanding of Fanconi anemia (FA) pathway function in hematopoietic stem a...
Our mechanistic understanding of Fanconi anemia (FA) pathway function in hematopoietic stem and prog...
SummaryFanconi anemia (FA) is an inherited DNA repair deficiency syndrome. FA patients undergo progr...
Despite having well-characterized disease-associated mutations, the mechanisms underlying the progre...
Abstract Although p53 mutations are common in solid tumors, such mutations are found at a lower freq...
Fanconi anemia (FA) is a disorder of DNA repair that manifests as bone marrow (BM) failure. The lack...
International audienceGermline mutations affecting telomere maintenance or DNA repair may, respectiv...
Fanconi anemia is a DNA repair deficiency syndrome associating developmental anomalies, bone marrow ...
Fanconi anemia (FA) is a rare disease characterized by congenital defects, progressive bone marrow f...
Bone marrow failure (BMF) in Fanconi anemia (FA) patients results from dysfunctional hematopoietic s...
Hypersensitivity to cross-linking agents such as mitomycin C (MMC) is characteristic of cells from p...
Hematopoietic stem cells (HSCs) preserve their ability to self-renew and differentiate to different ...
Overactive p53 has been proposed as an important pathophysiological factor for bone marrow failure s...
AbstractFanconi anemia patients suffer from progressive bone marrow failure. An overactive p53 respo...
SummaryOur mechanistic understanding of Fanconi anemia (FA) pathway function in hematopoietic stem a...
Our mechanistic understanding of Fanconi anemia (FA) pathway function in hematopoietic stem and prog...
SummaryFanconi anemia (FA) is an inherited DNA repair deficiency syndrome. FA patients undergo progr...
Despite having well-characterized disease-associated mutations, the mechanisms underlying the progre...
Abstract Although p53 mutations are common in solid tumors, such mutations are found at a lower freq...
Fanconi anemia (FA) is a disorder of DNA repair that manifests as bone marrow (BM) failure. The lack...
International audienceGermline mutations affecting telomere maintenance or DNA repair may, respectiv...
Fanconi anemia is a DNA repair deficiency syndrome associating developmental anomalies, bone marrow ...
Fanconi anemia (FA) is a rare disease characterized by congenital defects, progressive bone marrow f...
Bone marrow failure (BMF) in Fanconi anemia (FA) patients results from dysfunctional hematopoietic s...
Hypersensitivity to cross-linking agents such as mitomycin C (MMC) is characteristic of cells from p...
Hematopoietic stem cells (HSCs) preserve their ability to self-renew and differentiate to different ...